INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 33S33 trades$5.33M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  5. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  6. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  7. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  8. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K

Form 4 transactions

68,022 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
DR
Diaz RichardDirector
HFFGHF Foods Group Inc.
Grant or award
A—
21.4K sh
Jul 7, 2026Jul 7, 2026
Page 557 of 1701
← PrevNext →
traded Jul 7, 2026
+0d
SEC Form 4

Evidence

21
BS
Black Michael ScottChief Revenue Officer
BARKBark, Inc.
Grant or award
A—
50.0K sh
Jul 3, 2026Jul 7, 2026
traded Jul 3, 2026
+4dSEC Form 4

Evidence

21
TJ
Tejada JenniferDirector, Executive Chair
PDPagerDuty, Inc.
Tax withholding
F$711K
71.2K sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

20
HA
Huet Melanie ArlenePresident, Home & Com - Home
NWLNEWELL BRANDS INC.
Option exercise
M$101K
17.2K sh
Jul 5, 2026Jul 7, 2026
traded Jul 5, 2026
+2dSEC Form 4

Evidence

20
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Open-market sale · 10b5-1 plan
SELL$1.29M
9,043 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

20
HH
Harris Isaac HosojiroDirector
LITELumentum Holdings Inc.
Grant or award
A—
374 sh
Mar 31, 2026Jul 7, 2026
traded Mar 31, 2026
+98dSEC Form 4

Evidence

20
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Open-market sale · 10b5-1 plan
SELL$1.29M
9,043 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

20
PF
Posthauer Robert F.President, Home & Com. - Com.
NWLNEWELL BRANDS INC.
Option exercise
M$106K
18.1K sh
Jul 5, 2026Jul 7, 2026
traded Jul 5, 2026
+2dSEC Form 4

Evidence

20
HH
Harris Isaac HosojiroDirector
LITELumentum Holdings Inc.
Grant or award
A—
320 sh
Apr 30, 2026Jul 7, 2026
traded Apr 30, 2026
+68dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$7,979
40 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$308K
1,540 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$362K
1,820 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

19
BH
Bost Hunter H.Director
BRBSBLUE RIDGE BANKSHARES, INC.
Grant or award
A$35K
9,694 sh
Jul 1, 2026Jul 7, 2026
traded Jul 1, 2026
+6dSEC Form 4

Evidence

19
LR
Lechleider RobertChief Medical Officer
IMNMImmunome Inc.
Option exercise · 10b5-1 plan
M$480K
55.0K sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

19
CH
Cozart HeatherDirector
BRBSBLUE RIDGE BANKSHARES, INC.
Grant or award
A$37K
10.3K sh
Jul 1, 2026Jul 7, 2026
traded Jul 1, 2026
+6dSEC Form 4

Evidence

19
HT
Holme TimothyCHIEF TECHNOLOGY OFFICER
QSQuantumScape Corp
Open-market sale · 10b5-1 plan
SELL$750K
103.0K sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

19
SE
Strandberg ErikChief Commercial Officer
NONENONEEBR Systems, Inc.
Grant or award
A—
50.0K sh
Jun 24, 2026Jul 7, 2026
traded Jun 24, 2026
+13dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$39K
200 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

19
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$46K
240 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

19
FJ
Fitzpatrick JenniferChief Legal Officer
SIONSionna Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$447K
10.3K sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

19
DW
Doherty Gary W.Chief Financial Officer
NONENONEEBR Systems, Inc.
Grant or award
A—
60.0K sh
Jun 24, 2026Jul 7, 2026
traded Jun 24, 2026
+13dSEC Form 4

Evidence

19
RN
Reynolds Randolph N JrDirector
BRBSBLUE RIDGE BANKSHARES, INC.
Grant or award
A$24K
6,602 sh
Jul 1, 2026Jul 7, 2026
traded Jul 1, 2026
+6dSEC Form 4

Evidence

19
HM
Hendricksen MichaelChief Operating Officer
NONENONEEBR Systems, Inc.
Grant or award
A—
54.0K sh
Jun 24, 2026Jul 7, 2026
traded Jun 24, 2026
+13dSEC Form 4

Evidence

18
WH
Wilson HowardStrategic Advisor
PDPagerDuty, Inc.
Tax withholding
F$150K
15.1K sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

18
HW
Hershman Lisa W.Director
ECHOEchoStar CORP
Option exercise
M$245K
10.0K sh
Jul 1, 2026Jul 7, 2026
traded Jul 1, 2026
+6dSEC Form 4

Evidence

18
PD
Peck Michael DPresident
VFLEXFIRST TRUST ALTERNATIVE OPPORTUNITIES FUND
Other acquisition or disposition
J$8.16
0 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

18
HH
Harris Isaac HosojiroDirector
LITELumentum Holdings Inc.
Tax withholding
F$107K
125 sh
May 29, 2026Jul 7, 2026
traded May 29, 2026
+39dSEC Form 4

Evidence

18
PD
Peck Michael DPRESIDENT
FTECXFirst Trust Enhanced Private Credit Fund
Other acquisition or disposition
J$1,065
113 sh
Jun 30, 2026Jul 7, 2026
traded Jun 30, 2026
+7dSEC Form 4

Evidence

18
CE
Chad EisenbergTreasurer
VFLEXFIRST TRUST ALTERNATIVE OPPORTUNITIES FUND
Other acquisition or disposition
J$8.16
0 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

18
CE
Chad EisenbergTREASURER
FTECXFirst Trust Enhanced Private Credit Fund
Other acquisition or disposition
J$1,065
113 sh
Jun 30, 2026Jul 7, 2026
traded Jun 30, 2026
+7dSEC Form 4

Evidence

18
PD
Peck Michael DPRESIDENT
FTECXFirst Trust Enhanced Private Credit Fund
Other acquisition or disposition
J$8.85
1 sh
Jun 30, 2026Jul 7, 2026
traded Jun 30, 2026
+7dSEC Form 4

Evidence

18
CE
Chad EisenbergTREASURER
FTECXFirst Trust Enhanced Private Credit Fund
Other acquisition or disposition
J$8.85
1 sh
Jun 30, 2026Jul 7, 2026
traded Jun 30, 2026
+7dSEC Form 4

Evidence

17
PM
Pauls MatthewDirector
PTHSPelthos Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$18K
692 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

17
GP
Greenleaf PeterDirector
PTHSPelthos Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$2,318
85 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

17
FM
Friedberg Ezra MDirector
PTHSPelthos Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$14K
534 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

17
LD
Lam DennisDirector
HFFGHF Foods Group Inc.
Grant or award
A—
21.4K sh
Jul 7, 2026Jul 7, 2026
traded Jul 7, 2026
+0dSEC Form 4

Evidence

17
XC
Xu Cong ClaireSVP, Clinical Development
NBPNovaBridge Biosciences
Open-market sale
SELL$3,992
4,485 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

17
UJ
Uczekaj JohnDirector, President and COO
AIROAIRO Group Holdings, Inc.
Open-market sale
SELL$1,195
154 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

17
GP
Greenleaf PeterDirector
PTHSPelthos Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$19K
712 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

17
FM
Friedberg Ezra MDirector
PTHSPelthos Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$656
24 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence